PINC Fair Value & Analysis
Health Care · US · Market cap $4.1B
PINC
PINC · US
Fair value as of: Jul 18, 2026
From 21 valuation models · updated 23 days ago
Share price −0.1% over the past month.
A solid business, but screening 80% overvalued on our models.
What matters now
- The price sits above even our optimistic bull case ($10.20). The favourable scenario is already priced in.
- Solid but not exceptional quality (60/100) and above fair value, neither a clear bargain nor a standout compounder.
- The models converge in a tight band ($8.94 to $10.20), unusually little disagreement for a valuation.
Price vs Fair Value (5 years)
White line = price, green steps = our fair value per fiscal year, dashed = 300-day average. As of Jul 18, 2026.
How to read this chart
60‑month range $17.16 – $50.29 · fair‑value band $8.94 – $10.20 · the $49.98 price screens above the $10.20 fair value. Dashed = 300-day average. As of Jul 18, 2026.
Analysis
PINC (PINC) currently trades at $49.98, while our model-based Fair Value estimate is $10.20, implying the stock looks roughly 79.6% overvalued today. The Quality Score stands at 60/100 (solid quality), in the Health Care sector. Bear case: priced above our estimate, the market already discounts strong expectations. Bull case: above-average quality can justify a premium, the entry price still matters most (evidence: high).
Over the trailing twelve months, PINC generated revenue of $1.0B at a net margin of -3.3%. Revenue declined 3.3% year over year. It earns a return on equity of 0.9%. Net debt stands at $198M. Fundamentals as of Jul 18, 2026
Our scenario range runs from $8.94 (bear case) to $10.20 (bull case); at $49.98, the current price sits above that range. Bear and bull are the same models run on conservative and optimistic assumptions (margins, growth, valuation multiples), so a plausible valuation range, not a price target. The share trades about 1% below its 52-week high and 159% above its 52-week low, currently below its 200-day average.
Fair Value models
Each model estimates fair value its own way; the Fair Value above is the evidence-weighted blend. Evidence (0–100) measures how completely this model’s inputs are available: well-fed models carry more weight in the blend. The spread across models is intentional, each one stresses a different value driver; dividend models, for instance, come out structurally low when payout is small.
All 21 models by family
Widest divergence: DCF Models ($24.56) versus Earnings-Based ($2.43). Highest evidence: Growth DCF (80).
Key figures & financial health
More key figures
Figures from reported company fundamentals · as of Jul 18, 2026. TTM = trailing twelve months.
Quality Score breakdown
Of which business quality 59 · Market factors (momentum, volatility) 84
Non-valuation factor families (profitability, growth, cashflow, financial strength, momentum …), each academically grounded. Valuation itself sits in the Fair Value and is deliberately excluded here to avoid double-counting.
About the company
Under normal circumstances, the fund invests at least 80% of its investable assets in securitized credit investments and other similar credit instruments, including derivative instruments that provide exposure to securitized credit investments and other similar credit instruments. The fund is non-diversified.
Company description, as reported by the company or data provider.
Revenue & earnings trend
FY2021 – FY2025 · reported fiscal years
PINC reported revenue of $1.0B in FY2025 versus $1.7B in FY2021, a compound −12.4%/yr. Reported net income was $20.3M in FY2025, compounding −48.5%/yr from FY2021.
Watch PINC: get an alert when its fair value changes →
Peer Group
Health Care · 2228 stocks
How this stock ranks against its sector: the green marker is this stock, the band is the typical 25–75% peer range, and the tick is the median.
Valuation Multiples vs Health Care median · lower = cheaper
Snowflake
Five quick dimensions, each 0 to 100: VALUE (fair-value potential), FUTURE (revenue growth), PAST (return on equity), HEALTH (low debt), DIVIDEND (yield). Green = this stock, grey = typical sector peer.
VALUE 0: the price sits above our fair-value range.
Values & ESG
Does this company touch areas you may want to avoid? The classification is inferred from sector and industry.
ESG scores are not available for this stock yet. Values and ESG data are contextual and can differ between providers.
Explore undervalued stocks
More undervalued Healthcare stocks →
Frequently asked questions
Is PINC overvalued or undervalued?
What is the fair value of PINC?
What is the quality score of PINC?
What is the revenue of PINC?
What is the net profit margin of PINC?
How we calculate Fair Value
Each company is valued through a stack of independent intrinsic-value models (DCF variants, residual-income, multiples and more), blended into one family-balanced consensus and weighted by how much trustworthy data backs it. A separate quality layer scores the fundamentals. Every input is real reported data, nothing guessed.
Track PINC and try Pro for 14 days
One email gets you 14 days of full Pro (review alerts, the 35,000+ stock screener, the diversification check) plus the monthly Top-25 report of the most undervalued quality stocks. No card, cancel anytime.
Zero risk: nothing is ever charged. After 14 days you decide whether to stay.